Dissociation of DNA from Histone by Reaction of Anti-cancer Drug cis-Diamminedichloroplatinum(II) with DNA-Histone Complexes Used as Cellular Model
スポンサーリンク
概要
- 論文の詳細を見る
Although both cis-diamminedichloroplatinum (II) (cisplatin or cis-DDP) and frans-diamminedichloroplatinum (II) bind to DNA, only cis-DDP is widely used as a chemotherapeutic agent ; the stereoisomer trans-DDP is inactive. DNA, generally, is wound around the histone core in the nucleus of living cells and forms the nucleosome structure. To understand the essentially different anticancer activities of cis-DDP and trans-DDP, it is necessary to investigate the interaction of cis-DDP (or trans-DDP) with DNA around the histone in the nucleosome. Here, we used φX174DNA-histone^<LNCap> complexes prepared by the reaction of φX174DNA with histone^<LNCap> extracted from LNCaP cells. We first show that the ability of cis-DDP to dissociate the DNA from φX174DNA-histone^<LNCap>, as a nucleosome model, is much stronger than that of trans-DDP. As a result of the action of cis-DDP, the DNA in the nucleosome is rendered naked, and the naked DNA is vulnerable to cis-DDP (or other drugs). This study describes a new model showing that the difference in the activities of cis-DDP and trans-DDP is related to the difference in their abilities to dissociate the DNA from the nucleosome.
- 2007-04-01
著者
-
Kobayashi Shigeki
Division Of Analytical Chemistry Of Medicines Showa Pharmaceutical University
-
Nakagawa Sayaka
Division Of Analytical Chemistry Of Medicines Showa Pharmaceutical University
-
KOYAMA Yuhki
Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University
-
KIKUCHI Sachie
Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University
-
Koyama Yuhki
Division Of Analytical Chemistry Of Medicines Showa Pharmaceutical University
-
Kikuchi Sachie
Division Of Analytical Chemistry Of Medicines Showa Pharmaceutical University
-
Kobayashi Shigeki
Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University
関連論文
- Products of Thymine Oxygenation by a Non-heme Oxygenation Model, FeII(MeCN)62+–Ac2O–H2O2, and the Transition State Model between Oxoiron and Thymine
- PJ-375 Carperitide, Atrial Natriuretic Peptide, Improves Hemoglobin Level in Acute Heart Failure(PJ063,Heart Failure (Treatment) 1 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-068 Abnormally Tight Domain-Domain Interaction at Mutation Site could be a Primary Cause of Catecholaminergic Polymorphic Ventricular Tachycardia(PJ012,Calcium Handling, Cardiac Function (Basic) (M),Poster Session (Japanese),The 73rd Annual Scientific
- PJ-203 Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia : Insights from a RyR2 R2474S/+ knock-in mouse model(Arrhythmia, basic(05)(A),Poster Session(Japanese),The 72nd Annual Scient
- FRS-017 Enhanced Sensitivity of the Cardiac Ryanodine Receptor to Activation by Luminal Ca^ as a Primary Cause of CPVT(New Insights into Basic Mechanism of Arrhythmia(A),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circ
- PJ-765 Scavenging Free Radicals by Low-dose Carvedilol Prevents Redox-dependent Ca^ Leak via Stabilization of Ryanodine Receptor in Heart Failure(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society
- PJ-103 Defective Domain-Domain Interaction within Ryanodine Receptor as a Critical Cause of Diastolic Ca^ Spark in Cardiomyocytes(Excitation-contraction coupling/Ion channel, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-076 Correction of Defective Inter-Domain Interactions within Ryanodine Recepter by Dantrolene May be a Potent Therapeutic Strategy against Lethal Arrhythmia(Arrhythmia (basic), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-402 A Domain Which Has a Strong Effect to Stabilize the Ryanodine Receptor Exists inside the Ryanodine Receptor Itself(Heart failure, basic-5 (M) PJ68,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
- PJ-400 β-blocker Ameliorates Intracellular Ca^ Handling in Heart Failure via Correction of Defective Inter-domain Interaction within Ryanodine Receptor(Heart failure, basic-5 (M) PJ68,Poster Session (Japanese),The 70th Anniversary Annual Scientific Me
- PJ-175 Defective Inter-domain Interaction within the Ryanodine Recepter Plays a Key Role in the Pathogenesis of Heart Failure(Excitation-contraction coupling/Ion channel-2 (A) PJ30,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting o
- OJ-143 Urinary 8-Hydroxy-2' -Deoxyguanosine Level reflects symptomatic status and severity of systolic dysfunction in Patients with Chronic Heart Failure(Heart failure, clinical(05)(M),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting of the
- 1 Defective Inter-domain Interaction within the Ryanodine Receptor Underlies a Common Pathogenic Mechanism of Heart Failure and Lethal Arrhythmia(Subcellular Remodeling in the Failing Heart,Symposium 10 (SY-10) (A),The 73rd Annual Scientific Meeting of Th
- Differed Ca^ Regulatory Effect of Candesartan or a New Cardioprotective Agent JTV519 on Improvement of Isoproterenol-Induced Dysfunction in Rats
- Valsartan Restores Normal FKBP12.6-RyR Interaction by a Strong Inhibition of PKA-Mediated Hyperphosphorylation of RyR in Heart Failure
- OJ-019 Dantrolene Stabilizes Domain-Domain Interactions within the Ryanodine Receptor in Failing Hearts(Heart failure, basic-2 (M) OJ4,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- A novel cardioprotective agent, JTV519 improves cardiac function by restoring Ca^ -release function of cardiac sarcoplasmic reticulum in heart failure
- Propranolol prevents the development of heart failure by FKBP12.6-mediated stabilization of ryanodine receptor in sarcoplasmic reticulum
- FKBP12.6-mediated stabilization of calcium release channel (ryanodine receptor) as a novel therapeutic target in heart failure
- Diastereomer-Specific Effects of Double-Stranded Peptides Conjugated with-L-Tyr-L-Phe-or-L-Tyr-D-Phe-Residues on Tyrosine : Phosphorylation and Inhibition of src^NRK, A431, MCF-7, and DU145 Cell Growth
- Extrinsic rapid electrical stimulation modulates sarcoplasmic reticulum Ca^ proteins of cultured rat cardiomyocytes
- Potent 2,2-Diphenyl-1-picrylhydrazyl Radical-Scavenging Activity of Novel Antioxidants, Double-Stranded Tyrosine Residues Conjugating Pyrocatechol
- Assessment of the Brain Areas Perfused by Superselective Intra-arterial Chemotherapy Using Single Photon Emission Computed Tomography with Technetium-99m-Hexamethyl-propyleneamine Oxime : Technical Note
- Topological Differences in the Interaction of Human DNA Topoisomerase I with DNA-Histone Complexes Modified by cis- and trans-DDP
- Dissociation of DNA from Histone by Reaction of Anti-cancer Drug cis-Diamminedichloroplatinum(II) with DNA-Histone Complexes Used as Cellular Model
- Urinary 8-Hydroxy-2'-Deoxyguanosine as a Novel Biomarker for Predicting Cardiac Events and Evaluating the Effectiveness of Carvedilol Treatment in Patients With Chronic Systolic Heart Failure
- Low-Dose β-Blocker in Combination With Milrinone Safely Improves Cardiac Function and Eliminates Pulsus Alternans in Patients With Acute Decompensated Heart Failure
- Key Role of Chemical Hardness to Compare 2,2-Diphenyl-1-picrylhydrazyl Radical Scavenging Power of Flavone and Flavonol O-Glycoside and C-Glycoside Derivatives